Regular monitoring and early detection strategies are important for those at higher risk, or choosing to not receive these injectables is often the best solution
Hepatology (2004) 40:18594
They may be caused by dehydration, but in rare cases, headaches can occur due to low blood sugar, another side effect of Wegovy
Although these results are still at the preclinical stage, they suggest a therapeutic potential for GHK-Cu that extends well beyond the cosmetic domain
FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials While not indicated for weight loss, Mounjaro led to significantly greater weight reductions versus comparators in a key secondary endpoint Mounjaro represents the first new class of diabetes medicines introduced in nearly a decade and is expected to be available in the As the first and only FDA-approved GIP and GLP-1 receptor agonist, Mounjaro is a single molecule that activates the body's receptors for GIP and GLP-1, which are natural incretin hormones
(2008) 59 (Suppl